NutriBand Inc.
About NutriBand Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. Company operates in two reportable segments namely, Sales of Goods and Services. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2026
- $2.0M
- Net income
- -$8.2M
- Total assets
- $7.5M
- Market cap
- $43.5M
- Gross margin
- 27.8%
- Operating margin
- -408.4%
- Net margin
- -404.1%
Source: SEC EDGAR · updated Jun 8, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $2.0M
- Cost of revenue
- $1.5M
- Gross profit
- $566.3K
- Operating expenses
- $8.9M
- Operating income
- -$8.3M
- Net income
- -$8.2M
- EPS (basic)
- $-2.58
- EPS (diluted)
- $-2.58
Balance sheet
- Total assets
- $7.5M
- Current assets
- $5.0M
- Total liabilities
- $868.4K
- Current liabilities
- $784.3K
- Shareholders’ equity
- $6.7M
Cash flow
- Operating cash flow
- -$5.1M
- Investing cash flow
- -$5.3K
- Financing cash flow
- $5.4M
- Net cash flow
- $263.1K
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year
52-week range
- Market cap
- $43.5M
- EPS (diluted)
- $-2.58
- Shares outstanding
- 12.3M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Jun 20, 2017
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Reported a net loss of $8.2M in FY2026.
- Revenue grew 43% from FY2022 to FY2026.
- Gross margin of 27.8%, net margin -404.1%.
- Trading 67% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review NutriBand Inc..
Write a review
News about NutriBand Inc.
News & sentiment via Polygon.io
